These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6995491)

  • 1. An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats.
    Larsson P; Kaijser B; Baltzer IM; Olling S
    J Clin Pathol; 1980 Apr; 33(4):408-12. PubMed ID: 6995491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies on hematogenous and ascending pyelonephritis in rats].
    Adler CP; Ritzmann H; Zollinger HU
    Virchows Arch A Pathol Pathol Anat; 1969; 347(4):277-95. PubMed ID: 4896845
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental pyelonephritis in dogs. I. Confirmation by antibody response.
    Harrison LH; Cass AS; Bullock BC; Cox CE
    J Urol; 1973 Feb; 109(2):163-6. PubMed ID: 4568307
    [No Abstract]   [Full Text] [Related]  

  • 4. The inflammatory reaction and urinary leucocytes in ascending urinary-tract infections. An experimental study on rabbits infected with Proteus vulgaris X 19 and Escherichia coli 06.
    Gnarpe H; Olding L
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(2):208-14. PubMed ID: 4922733
    [No Abstract]   [Full Text] [Related]  

  • 5. Morphological lesions of the rat urinary tract induced by inoculation of mycoplasmas and other urinary tract pathogens.
    Larsson PA; Cano M; Grenabo L; Brorson JE; Hedelin H; Pettersson S; Johansson SL
    Urol Int; 1989; 44(4):210-7. PubMed ID: 2678669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EXPERIMENTAL PYELONEPHRITIS IN THE MOUSE PRODUCED BY ESCHERICHIA COLI, PSEUDOMONAS AERUGINOSA AND PROTEUS MIRABILIS.
    GORRILL RH; DENAVASQUEZ SJ
    J Pathol Bacteriol; 1964 Jan; 87():79-87. PubMed ID: 14106358
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute obstructive pyelonephritis (experimental research)].
    Rubtsov IuS
    Urol Nefrol (Mosk); 1986; (4):22-4. PubMed ID: 3532486
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of ascending pyelonephritis in mice by urease inhibitors.
    Aronson M; Medalia O; Griffel B
    Nephron; 1974; 12(2):94-104. PubMed ID: 4600535
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
    Johnson DE; Russell RG; Lockatell CV; Zulty JC; Warren JW; Mobley HL
    Infect Immun; 1993 Jul; 61(7):2748-54. PubMed ID: 8514376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental pyelonephritis in the monkey. IV. Vesicoureteral reflux and bacteria.
    Roberts JA
    Invest Urol; 1976 Nov; 14(3):198-201. PubMed ID: 825481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
    Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL
    Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis.
    Silverblatt FJ; Ofek I
    J Infect Dis; 1978 Nov; 138(5):664-7. PubMed ID: 361900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental pyelonephritis in dogs. Result of urinary infection and vesicoureteral reflux.
    Harrison L; Cass A; Bullock B; Boyce W; Cox C
    Urology; 1973 May; 1(5):439-43. PubMed ID: 4589604
    [No Abstract]   [Full Text] [Related]  

  • 14. Current concepts of pyelonephritis.
    Braude AI
    Medicine (Baltimore); 1973 Jul; 52(4):257-64. PubMed ID: 4578990
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental pyelonephritis from Proteus mirabilis L forms in rats].
    Toshkov A; Kuiumdzhiev A; Zakharieva S; Georgiev D; Gumpert I
    Acta Microbiol Virol Immunol (Sofiia); 1977; 6():42-8. PubMed ID: 343511
    [No Abstract]   [Full Text] [Related]  

  • 16. [An experimental model of ascending pyelonephritis in rats].
    Chilimoniuk M; Jodczyk JK; Dzierzanowska D; Musierowicz A; Korfel Z
    Med Dosw Mikrobiol; 1977; 29(1):67-71. PubMed ID: 323605
    [No Abstract]   [Full Text] [Related]  

  • 17. Conduit urinary diversion and urinary-tract infection. II. Raised serum antibody titers against Escherichia coli and Proteus mirabilis in relation to bacteriologic findings.
    Bergman B; Kaijser B; Nilson AE
    Scand J Urol Nephrol; 1979; 13(1):71-7. PubMed ID: 368977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental studies on the chemotherapeutic effect on retrograde Proteus pyelonephritis in rats (author's transl)].
    Orito M
    Nihon Hinyokika Gakkai Zasshi; 1981 Jun; 72(6):680-93. PubMed ID: 7026854
    [No Abstract]   [Full Text] [Related]  

  • 19. THE FATE OF PSEUDOMONAS AERUGINOSA, PROTEUS MIRABILIS AND ESCHERICHIA COLI IN THE MOUSE KIDNEY.
    GORRILL RH
    J Pathol Bacteriol; 1965 Jan; 89():81-8. PubMed ID: 14263500
    [No Abstract]   [Full Text] [Related]  

  • 20. Site of action of nitrofurantoin in experimental urinary tract infection.
    Rocha H; da Silva Teles E; Barros M
    Appl Microbiol; 1969 Oct; 18(4):547-9. PubMed ID: 4905033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.